 Gongyi Zhang
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Demethylases | 3 | 2020 | 31 | 1.820 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 108 | 1.550 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 60 | 1.430 |
Why?
| | Arginine | 3 | 2022 | 265 | 0.930 |
Why?
| | Histones | 3 | 2020 | 588 | 0.900 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.830 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 28 | 0.760 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 758 | 0.750 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.690 |
Why?
| | RNA Polymerase II | 2 | 2020 | 317 | 0.680 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 149 | 0.670 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 70 | 0.640 |
Why?
| | Protein Binding | 6 | 2024 | 2120 | 0.640 |
Why?
| | Methyltransferases | 1 | 2020 | 70 | 0.630 |
Why?
| | Mutation | 5 | 2022 | 3710 | 0.620 |
Why?
| | Glycoproteins | 4 | 2014 | 338 | 0.610 |
Why?
| | Phosphoproteins | 4 | 2014 | 332 | 0.600 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2020 | 200 | 0.590 |
Why?
| | Leukemia | 1 | 2020 | 229 | 0.570 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2020 | 327 | 0.570 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 380 | 0.570 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 57 | 0.550 |
Why?
| | Sirtuin 2 | 1 | 2017 | 24 | 0.540 |
Why?
| | Sirtuins | 1 | 2017 | 39 | 0.540 |
Why?
| | Protein Conformation | 6 | 2018 | 861 | 0.510 |
Why?
| | Protein Folding | 1 | 2017 | 264 | 0.510 |
Why?
| | Transcription, Genetic | 2 | 2024 | 1416 | 0.470 |
Why?
| | Protein Structure, Tertiary | 3 | 2020 | 841 | 0.470 |
Why?
| | Antiviral Agents | 1 | 2021 | 712 | 0.470 |
Why?
| | Protein Unfolding | 1 | 2014 | 31 | 0.460 |
Why?
| | Methylation | 3 | 2022 | 230 | 0.450 |
Why?
| | Urea | 1 | 2014 | 76 | 0.450 |
Why?
| | beta Catenin | 1 | 2014 | 223 | 0.400 |
Why?
| | Binding Sites | 4 | 2021 | 1249 | 0.360 |
Why?
| | Lipids | 1 | 2014 | 625 | 0.350 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 454 | 0.350 |
Why?
| | Staphylococcus aureus | 2 | 2006 | 434 | 0.340 |
Why?
| | Crystallography, X-Ray | 4 | 2018 | 435 | 0.340 |
Why?
| | Antibodies, Neutralizing | 2 | 2022 | 265 | 0.320 |
Why?
| | Ligands | 3 | 2022 | 621 | 0.320 |
Why?
| | Models, Molecular | 5 | 2024 | 1486 | 0.320 |
Why?
| | Immunity, Innate | 2 | 2014 | 803 | 0.310 |
Why?
| | Bacterial Proteins | 2 | 2006 | 833 | 0.300 |
Why?
| | Protein Denaturation | 2 | 2017 | 74 | 0.260 |
Why?
| | Animals | 13 | 2022 | 35307 | 0.240 |
Why?
| | RNA | 1 | 2010 | 880 | 0.220 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 161 | 0.210 |
Why?
| | Humans | 19 | 2023 | 129248 | 0.210 |
Why?
| | Antigens | 2 | 2015 | 356 | 0.200 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 126 | 0.190 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.190 |
Why?
| | DNA Helicases | 1 | 2023 | 149 | 0.180 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 52 | 0.180 |
Why?
| | DNA Replication | 1 | 2023 | 227 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 107 | 0.180 |
Why?
| | Mice | 9 | 2020 | 16915 | 0.180 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 88 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2024 | 383 | 0.170 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.170 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 108 | 0.170 |
Why?
| | Blotting, Western | 2 | 2020 | 1204 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 138 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 530 | 0.170 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 109 | 0.160 |
Why?
| | Protein Domains | 1 | 2020 | 253 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1202 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 442 | 0.150 |
Why?
| | Amino Acids | 1 | 2022 | 486 | 0.150 |
Why?
| | Pneumonia, Mycoplasma | 2 | 2010 | 56 | 0.150 |
Why?
| | Nucleosomes | 1 | 2020 | 137 | 0.150 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 22 | 0.150 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2018 | 54 | 0.150 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 351 | 0.140 |
Why?
| | Kinetics | 1 | 2021 | 1644 | 0.140 |
Why?
| | Proteolysis | 1 | 2018 | 167 | 0.140 |
Why?
| | Acylation | 1 | 2017 | 28 | 0.140 |
Why?
| | Proline | 1 | 2017 | 76 | 0.140 |
Why?
| | Mass Spectrometry | 1 | 2020 | 713 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2018 | 4076 | 0.130 |
Why?
| | Catalysis | 1 | 2017 | 307 | 0.130 |
Why?
| | Phosphorylation | 1 | 2020 | 1710 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1446 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1204 | 0.120 |
Why?
| | Fibroblasts | 2 | 2018 | 947 | 0.120 |
Why?
| | Wound Healing | 1 | 2018 | 305 | 0.120 |
Why?
| | Signal Transduction | 2 | 2010 | 4926 | 0.120 |
Why?
| | Hybridomas | 1 | 2015 | 235 | 0.120 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 87 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2022 | 2703 | 0.120 |
Why?
| | HEK293 Cells | 2 | 2014 | 696 | 0.110 |
Why?
| | Lysine | 1 | 2017 | 286 | 0.110 |
Why?
| | Circular Dichroism | 1 | 2014 | 147 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 100 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 944 | 0.110 |
Why?
| | Amino Acid Sequence | 3 | 2024 | 2056 | 0.110 |
Why?
| | DNA Primers | 1 | 2014 | 510 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2018 | 2374 | 0.100 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 257 | 0.100 |
Why?
| | Mice, Knockout | 2 | 2017 | 2871 | 0.100 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 3201 | 0.100 |
Why?
| | Base Sequence | 2 | 2014 | 2146 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 616 | 0.100 |
Why?
| | Sulfhydryl Compounds | 1 | 2014 | 187 | 0.100 |
Why?
| | Water | 1 | 2014 | 440 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2015 | 848 | 0.090 |
Why?
| | Dimerization | 2 | 2014 | 191 | 0.090 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2010 | 8 | 0.090 |
Why?
| | TRPC Cation Channels | 1 | 2010 | 14 | 0.090 |
Why?
| | Respiratory Mucosa | 2 | 2010 | 307 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 86 | 0.090 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 47 | 0.080 |
Why?
| | Binding, Competitive | 1 | 2010 | 206 | 0.080 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 83 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2014 | 692 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 113 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2015 | 815 | 0.080 |
Why?
| | Substrate Specificity | 1 | 2010 | 368 | 0.080 |
Why?
| | Eosinophils | 1 | 2012 | 324 | 0.080 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 114 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2835 | 0.070 |
Why?
| | Mycoplasma pneumoniae | 1 | 2007 | 56 | 0.070 |
Why?
| | Respiratory Hypersensitivity | 1 | 2007 | 64 | 0.070 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 706 | 0.070 |
Why?
| | Helix-Turn-Helix Motifs | 1 | 2006 | 5 | 0.060 |
Why?
| | Pneumonia | 1 | 2012 | 616 | 0.060 |
Why?
| | Cations, Divalent | 1 | 2006 | 54 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2006 | 227 | 0.060 |
Why?
| | Virulence | 1 | 2006 | 255 | 0.060 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2024 | 18 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2007 | 505 | 0.060 |
Why?
| | Transcription Factor TFIID | 1 | 2024 | 24 | 0.060 |
Why?
| | Insulin | 1 | 2014 | 2325 | 0.050 |
Why?
| | Histone Acetyltransferases | 1 | 2024 | 61 | 0.050 |
Why?
| | DNA | 1 | 2010 | 1396 | 0.050 |
Why?
| | Protein Subunits | 1 | 2024 | 234 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2023 | 53 | 0.050 |
Why?
| | Homologous Recombination | 1 | 2023 | 23 | 0.050 |
Why?
| | Protein Multimerization | 1 | 2024 | 178 | 0.050 |
Why?
| | Crystallization | 1 | 2003 | 138 | 0.050 |
Why?
| | Molecular Structure | 1 | 2004 | 478 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 184 | 0.050 |
Why?
| | Protein Structure, Secondary | 1 | 2003 | 340 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2003 | 321 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 323 | 0.040 |
Why?
| | Keratinocytes | 1 | 2018 | 242 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2012 | 1304 | 0.030 |
Why?
| | Transcription Factors | 1 | 2003 | 1647 | 0.030 |
Why?
| | Skin | 1 | 2018 | 726 | 0.030 |
Why?
| | Chemokine CCL24 | 1 | 2012 | 11 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2014 | 588 | 0.020 |
Why?
| | Ovalbumin | 1 | 2012 | 178 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2012 | 212 | 0.020 |
Why?
| | Interleukin-13 | 1 | 2012 | 147 | 0.020 |
Why?
| | Th2 Cells | 1 | 2012 | 171 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1028 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 361 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 644 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 389 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 877 | 0.020 |
Why?
| | Lipoproteins | 1 | 2007 | 171 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2007 | 262 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 450 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1247 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 839 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2010 | 1063 | 0.010 |
Why?
| | Models, Biological | 1 | 2010 | 1722 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2779 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5439 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 2537 | 0.010 |
Why?
| | Lung | 1 | 2012 | 3926 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3628 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2007 | 4057 | 0.010 |
Why?
| | Female | 2 | 2014 | 68543 | 0.010 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|